Ashfield Healthcare Communications Expands Footprint with Argon Global Healthcare Network Alliance
The UK’s Ashfield Healthcare Communications and Argon Global Healthcare Network have announced that they have combined their capabilities to assist clients with managing their brands in existing locations and expanding into new.
“The complementary service offerings and greater geographical reach from Ashfield and Argon will provide clients a non-holding company approach to the global environment. Collectively this partnership provides our clients with unprecedented agility and access to a full breadth of communications services tailored with a deep understanding of cultural and business nuances for their regional and local needs,” a press release reports.
Ashfield Healthcare Communications president Doug Burcin commented: “I am delighted with this partnership in that it continues to deliver on our approach to being a truly global micro network. We have a well-established presence in the UK, Germany, Japan and US for delivering our solutions at the intersection of science, data and creativity so we are excited to come together with the Argon Global Healthcare Network to be able to deliver this on an even more global scale.”
Doug Burcin
Novo Nordisk, The United Laboratories Ink Exclusive License Agreement for Triple Receptor Agonist
March 25th 2025Under terms of the license agreement, Novo Nordisk will acquire the rights to develop and commercialize UBT251 outside of China for obesity and type 2 diabetes for an upfront payment of $200 million.
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
